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INTRODUCTION
Fibroadenoma is a common benign breast lesion occurring 
in 25% of asymptomatic women [1]. Although previous studies 
of patients with fibroadenoma report an increased risk of breast 
carcinoma compared to similarly aged women in the general 
population, malignant transformation from fibroadenoma to 
cancer is rare [2]. Furthermore, Worsham et al. [3] reported that 
the presence of fibroadenoma, regardless of whether the lesion 
was proliferative or nonproliferative, was protective against 
breast cancer progression, a result that conflicted with the 
findings of previous studies. Therefore, management of fibro-
adenomas has typically been conservative [4]. Lesions that 
show typical features of fibroadenomas are classified as Breast 
Imaging Reporting and Data System (BI-RADS) category 3; if 
the lesion is considered to be involuting, it is classified as BI-
RADS category 2.
In this article, we report a case of breast cancer that arose ad-
jacent to or from an involuting fibroadenoma. There have been 
several case reports and studies that retrospectively reviewed 
breast cancers that arose within fibroadenomas; however, none 
of these studies reported serial changes in radiologic features of 
the cancer site, including findings from mammography and 
ultrasound (US). In this article, we report a case of breast cancer 
that arose adjacent to or within a fibroadenoma. Data from the 
case reported here include mammographic, sonographic, and 
magnetic resonance (MR) images that were also correlated 
with pathologic features.
CASE REPORT
A 39-year-old woman with dense breast tissue underwent 
breast US as part of her regular screening exam at a local hos-
pital. The US revealed a 0.7 cm nodule located in the upper-
outer quadrant (UOQ) of her left breast, classified as BI-RADS 
category 3 (Figure 1). A follow-up US was recommended. 
Two years later, the patient revisited our hospital complain-
ing of a palpable mass in the UOQ of the left breast. US re-
vealed a 1.8 cm circumscribed isoechoic mass in the UOQ of 
her left breast. It appeared that the previously noted nodule 
had increased in size (157% over 2 years), and the nodule was 
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Fibroadenoma is a common benign breast lesion and its malig-
nant transformation is rare. There have been several case reports 
and studies that retrospectively reviewed breast cancers that 
arose within fibroadenomas; however, none of these studies re-
ported serial changes in radiologic features of the cancer, includ-
ing findings from mammography and ultrasound (US). We report 
a case of breast cancer arising adjacent to an involuting fibro 
adenoma in a 39-year-old woman who was undergoing serial 
follow-up after her fibroadenoma was diagnosed. Seven years 
after her diagnosis, the lesion showed evidence of coarse calcifica-
tions, a typical sign of involution. Four years later, US revealed a 
newly developed hypoechoic lesion with irregular margins and 
peripherally located calcifications adjacent to the fibroadenoma. 
A core biopsy was performed, and histopathological examina-
tion resulted in a diagnosis of invasive ductal carcinoma. When 
new suspicious features are observed in a fibroadenoma, radiolo-
gists should raise the concern for breast cancer and proceed 
with diagnosis and treatment accordingly.
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then classified as BI-RADS category 4A (Figure 2). This re-
classification indicated a need for US-guided core biopsy, 
which confirmed that the nodule was a fibroadenoma. Subse-
quent surgery was recommended, but the patient refused and 
elected to undergo regular follow-up instead.
The patient returned to our hospital after 5 years, because 
she had been told during a routine follow-up exam performed 
at an outside hospital that calcifications had newly developed 
in the lesion. Her mammogram showed macrocalcifications 
that were centrally located within the lesion and that had a 
“popcorn-like” appearance (Figure 3A). US revealed that the 
nodule had decreased in size while also developing internal 
calcifications, findings indicative of an involuting fibroadeno-
ma (Figure 3B). Because she was scheduled to undergo hor-
mone replacement therapy for menopausal symptoms, the 
patient was concerned about the presence of calcifications. 
She wished to have a repeat biopsy of the lesion prior to initi-
ating hormone replacement therapy. The rebiopsy confirmed 
the diagnosis of fibroadenoma, and the patient began hor-
monal therapy, which she continued for 3 years.
Another 4 years later, 11 years after the initial fibroadenoma 
Figure 1. Initial ultrasound image of left breast. Ultrasound image of a 
0.7 cm, isoechoic, probably benign nodule in the upper-outer portion (1 
o’clock) of the left breast.
Figure 2. Ultrasound image of left breast taken 2 years after original di-
agnosis. An ultrasound image taken 2 years after the original diagnosis, 
showing an 1.8 cm, circumscribed isoechoic mass lesion in the upper-
outer portion (1 o’clock) of the left breast, which had increased in size 
compared to the previously noted nodule. 
Figure 3. Radiologic images taken 5 years after the time when Figure 2 was taken. (A) Mammography. Mediolateral-oblique view (left) and cranial-
caudal view (right). The nodule shows newly developed calcifications. Macrocalcification was noted centrally within the lesion and had a “popcorn-
like” appearance. (B) Ultrasound. The image shows a 1.1 cm, newly developed, centrally located calcification that appears to be an isoechoic mass 
lesion in the upper-outer portion (1 o’clock) of the left breast, suggesting involuting fibroadenoma. Core biopsy confirmed this lesion as fibroadenoma. 
A B
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diagnosis, the patient revisited our imaging center because the 
nodule had increased in size, according to an US result she 
had received from her local hospital. The patient underwent 
mammography at our hospital; this showed that the fibroade-
noma was denser but the size of the lesion was similar com-
pared to that of her previous exam (Figure 4A). We also per-
formed US of the lesion, which revealed that the fibroadeno-
ma had enlarged eccentrically and was accompanied by a 
0.8× 1.3 cm, microlobulated hypoechoic lesion. No changes 
in the previously detected calcifications in the UOQ were not-
ed (Figure 4B). The lesion was classified as BI-RADS category 
4A, and a core biopsy was indicated. The biopsy targeted the 
eccentrically enlarged portion, which was delineated on the 
US exam. Biopsy confirmed that the lesion was an invasive 
ductal carcinoma (IDC). For preoperative evaluation, MR im-
aging was performed and revealed a 1.5 cm enhancing mass 
in the UOQ of the patient’s left breast, which correlated with 
the lesion detected on US (Figure 5). 
The patient underwent breast conservation surgery, which 
identified a 1.4 cm IDC (estrogen receptor 90% positive, pro-
Figure 5. Magnetic resonance imaging at an early phase after contrast 
injection with subtraction. Magnetic resonance imaging at an early 
phase after contrast injection with subtraction revealed an approximate-
ly 1.5 cm mass with arterial enhancing components (arrows) that corre-
lated well with microlobulated hypoechoic lesions on ultrasound; this le-
sion was confirmed for invasive ductal carcinoma. The unenhancing 
portion (arrowhead) is considered fibroadenoma.
Figure 4. Radiologic images taken 4 years after the time when Figure 3 
were taken. (A) Mammography. Mediolateral-oblique view (left) and cra-
nial-caudal view (right). It shows that the previously confirmed fibroade-
noma was denser but had not changed significantly in size over time. 
(B) Ultrasound. Transverse view (left) and longitudinal view (right). It 
shows that the previously noted, centrally located calcification was now 
shifted into the periphery, with the nodule increasing in size with micro-
lobulated margin (arrow) at the upper-outer portion (1 o’clock) of the left 
breast.A
B
294  Chae Jung Park, et al.
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2015.18.3.291
gesterone receptor 60% positive, human epidermal growth 
factor receptor 2 negative) abutting the previously confirmed 
fibroadenoma (Figure 6) without axillary metastasis. She un-
derwent postoperative definitive radiation therapy targeted to 
the left breast.
DISCUSSION
Fibroadenomas are common benign lesions of the breast 
that usually present as a single breast mass in young women 
[4]. There is some controversy regarding whether patients 
with fibroadenomas have an increased risk of subsequent 
breast cancer relative to other women. However, because ma-
lignant transformation from fibroadenoma is rarely reported, 
the management of fibroadenomas is typically conservative 
[4]. Complex fibroadenomas are a subtype of fibroadenoma 
that harbors one or more complex features, including epitheli-
al calcifications, papillary apocrine metaplasias, sclerosing ad-
enosis, or cysts larger than 3 mm [1]. The risk of developing 
breast cancer was found to be higher in patients with complex 
fibroadenomas than in those with noncomplex fibroadeno-
mas (3.1 times greater among women with complex fibroade-
nomas versus 1.89 times greater among women with non-
complex fibroadenomas, compared to control groups) [5].
There have been some case reports of breast cancer arising 
within a fibroadenoma; however, these reports lack imaging 
findings in which the cancer is distinguishable from the fibro-
adenoma. Abe et al. [6] reported a case of scirrhous-type IDC 
arising in a fibroadenoma. On US, the suspicious palpable le-
sion appeared to have ill-defined heterogeneously hypoechoic 
features; however, the fibroadenoma and cancer components 
could not be distinguished. Monsefi et al. [7] reported a case 
of mucinous subtype IDC arising within a fibroadenoma with 
mammography images only. The lesion appeared to have a 
well-circumscribed border without calcifications, suggesting a 
benign lesion, most likely fibroadenoma. However, surgery 
revealed it to be a mucinous subtype of IDC [7]. Thus, it was 
difficult to find clues of cancers arising within or adjacent to 
fibroadenomas on imaging findings. More recently, Iwamoto 
et al. [8] reported a case of breast IDC that was adjacent to 
one of multiple macrocalcified fibroadenomas in a patient 
who had undergone mastectomy for the primary IDC more 
than 13 years earlier. The sonographic findings in Iwamoto et 
al.’s case report were similar to ours, particularly with regard 
to the hypoechoic mass with a microlobulated margin and 
microcalcifications adjacent to the macrocalcifications of the 
fibroadenoma. However, at the time of IDC diagnosis, the pa-
tient in Iwamoto et al.’s case already had axillary lymph node 
metastasis and had progressed far more than was the case 
with our patient.
Our case evaluation has some strengths that are distin-
guished from other published reports. First, we reported serial 
imaging findings of the fibroadenoma over time, which al-
lowed us to demonstrate changes in the size of the lesion. 
During the follow-up, we could detect the newly developed 
malignant lesion adjacent to the fibroadenoma on the US im-
ages, based on regular screening mammography and US in a 
patient with heterogeneously dense breasts. We also correlated 
these findings with those of MR imaging performed during 
the preoperative evaluation. High-resolution ultrasonographic 
images enabled us to perform a targeted percutaneous biopsy 
of the suspicious lesion so that we were able to make the diag-
nosis of IDC before surgery, which is noteworthy because it 
meant we were able to diagnose IDC at an early stage (T1N0), 
without axillary lymph node metastasis.
Abe et al. [6] reviewed 15 cases of previously reported breast 
carcinomas occurring within fibroadenomas, among which 
carcinoma in situ was the dominant type (56.3%). They attrib-
uted this to the ability to make an earlier diagnosis of malig-
nant neoplasm coexisting with an easily palpable fibroadeno-
ma. However, in only two cases were these carcinomas < 2 cm 
in size. In fact, the presence of fibroadenoma may obscure a 
small-sized cancer that is within or adjacent to the fibroade-
noma if a meticulous evaluation is not undertaken. Therefore, 
it is encouraging that we were able to make a cancer diagnosis 
at an early stage based on regular screening mammography 
and US. However, we do not suggest that all involuting fibro-
adenomas require this type of follow-up. As many other pre-
Figure 6. Histological examination revealed invasive ductal carcinoma 
arising adjacent to the fibroadenoma (H&E stain, ×40). Histological ex-
amination revealed invasive ductal carcinoma (arrows) arising adjacent 
to the fibroadenoma (arrowheads) that is well distinguished from the 
fibroadenoma due to its distinct margin. The distance between invasive 
ductal carcinoma and fibroadenoma is measured as 500 µm.
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vious case reports have suggested, even if the fibroadenoma is 
a benign neoplasm that is unlikely to undergo malignant 
transformation, radiologists should pay attention when imag-
ing reveals newly developed suspicious features, such as irreg-
ular or microlobulated margins, increased size, or eccentric 
calcifications. Any changes that are newly detected should in-
crease the concern for cancer.
In conclusion, we discuss the serial radiologic and patho-
logic findings of a case of breast cancer that arose adjacent to 
an involuting fibroadenoma. Fibroadenomas themselves and 
the malignancies arising within them can exhibit variable fea-
tures on imaging studies. When new suspicious features are 
observed in a fibroadenoma, radiologists should raise the 
concern for breast cancer and proceed with diagnosis and 
treatment accordingly.
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